Safety, tolerability and pharmacokinetics and pharmacodynamics of inhaled once-daily umeclidinium in healthy adults deficient in CYP2D6 activity: a double-blind, randomized clinical trial.
about
Muscarinic antagonists in early stage clinical development for the treatment of asthma.Umeclidinium bromide and vilanterol trifenatate inhalation powder.Effect of severe renal impairment on umeclidinium and umeclidinium/vilanterol pharmacokinetics and safety: a single-blind, nonrandomized studyUmeclidinium for treating COPD: an evaluation of pharmacologic properties, safety and clinical use.Umeclidinium for the treatment of chronic obstructive pulmonary disease.Inhaled Umeclidinium in COPD Patients: A Review and Meta-Analysis.Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
P2860
Q30396144-AB1AF52B-CE4B-4832-B076-74E4F9F73F43Q33774769-86FFD410-C98E-4E71-A644-20951F100C5AQ34787196-38593E19-4BF7-45EE-9F23-4E478D55B8F4Q38258030-FCABEF2E-393D-4BC9-9901-625B79B6FF37Q38259862-B4ACECF6-CE17-4193-B0FE-7686CE949C79Q38692883-37C92646-397A-4E65-AEFD-8EA932F728FCQ38717900-ACDF2B55-57A5-4988-AA24-CD0173D4E3F7
P2860
Safety, tolerability and pharmacokinetics and pharmacodynamics of inhaled once-daily umeclidinium in healthy adults deficient in CYP2D6 activity: a double-blind, randomized clinical trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Safety, tolerability and pharm ...... nd, randomized clinical trial.
@en
Safety, tolerability and pharm ...... nd, randomized clinical trial.
@nl
type
label
Safety, tolerability and pharm ...... nd, randomized clinical trial.
@en
Safety, tolerability and pharm ...... nd, randomized clinical trial.
@nl
prefLabel
Safety, tolerability and pharm ...... nd, randomized clinical trial.
@en
Safety, tolerability and pharm ...... nd, randomized clinical trial.
@nl
P2093
P2860
P1476
Safety, tolerability and pharm ...... ind, randomized clinical trial
@en
P2093
Alison Donald
Anthony Cahn
James Blowers
Rashmi Mehta
P2860
P304
P356
10.1007/S40261-013-0109-6
P577
2013-09-01T00:00:00Z